Side Effect Management
Patients With COVID-19 Treated for Cancer at Risk for Thromboembolisms
January 18th 2024Patients recently treated for cancer who required hospitalization for COVID-19 were at risk for venous thromboembolisms (VTEs), recent research has found, with investigators determining that patients who experience a thromboembolic event (TEE) are at a 20% to 25% risk of death.